🇺🇸 FDA
Pipeline program

oxaliplatin

B4-2016-LGL

Phase 2 small_molecule active

Quick answer

oxaliplatin for Stomach Neoplasms is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Stomach Neoplasms
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials